Hereditary transthyretin-mediated amyloidosis, also known as ATTRv (v for variant) amyloidosis, is a rare, progressively debilitating, and fatal systemic disease caused by pathogenic variants in the transthyretin (TTR) gene [1–4]. This evidence concerns the gene TTR and amyloidosis.